J Y Ranchere - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Y Ranchere

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Bulletin Du Cancer|November 1, 1991

[Adverse effects of interleukin 2]A Ravaud, S Negrier, F Lakdja, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1992

Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancerM S Negrier, C N Pourreau, P A Palmer, et al.

Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999

Energy expenditure during allogeneic and autologous bone marrow transplantationV Chamouard Cogoluenhes, C Chambrier, M Michallet, et al.

Palliative Medicine|June 17, 2004

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international surveyAugusto Caraceni, Cinzia Martini, Ernesto Zecca, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Bulletin Du Cancer|November 1, 1991

[Adverse effects of interleukin 2]A Ravaud, S Negrier, F Lakdja, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1992

Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancerM S Negrier, C N Pourreau, P A Palmer, et al.

Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999

Energy expenditure during allogeneic and autologous bone marrow transplantationV Chamouard Cogoluenhes, C Chambrier, M Michallet, et al.

Palliative Medicine|June 17, 2004

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international surveyAugusto Caraceni, Cinzia Martini, Ernesto Zecca, et al.

Pageof 2